Mombo I. M. auteur aut IRD Fritz M. auteur aut IRD Becquart Pierre auteur aut IRD Liégeois Florian auteur aut IRD Elguero Eric auteur aut IRD Boundenga L. auteur aut IRD Mebaley T. N. auteur aut IRD Prugnolle F. auteur aut IRD Maganga G. D. auteur aut IRD Leroy Eric auteur aut IRD text journalArticle eng text/pdf reformatted digital access Based on a large study conducted on wild great ape fecal samples collected in regions of Gabon where previous human outbreaks of Ebola virus disease have occurred between 1994 and 2002, we provide evidence for prevalence of Zaire ebolavirus (EBOV)-specific antibodies of 3.9% (immunoglobulin G (IgG)) and 3.5% (immunoglobulin M (IgM)) in chimpanzees and 8.8% (IgG) and 2.4% (IgM) in gorillas. Importantly, we observed a high local prevalence (31.2%) of anti-EBOV IgG antibodies in gorilla samples. This high local rate of positivity among wild great apes raises the question of a spatially and temporally localized increase in EBOV exposure risk and the role that can be played by these animals as sentinels of the virus's spread or reemergence in a given area. specialized great ape Ebola Africa Luminex GABON 052 080 020 12 12 1347 [20 ] 2020 https://www.documentation.ird.fr/hor/fdi:010080528 10.3390/v12121347 [F B010080528] https://www.documentation.ird.fr/hor/fdi:010080528 https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers21-01/010080528.pdf IRD - Base Horizon / Pleins textes 2021-02-08 2025-02-24 fdi:010080528 fre